Sanofi Collaboration Drives Lexicon Pharma's (LXRX) 4Q Success; Wedbush Raises Price Target to $28
Go back to Sanofi Collaboration Drives Lexicon Pharma's (LXRX) 4Q Success; Wedbush Raises Price Target to $28| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.05 +0.01 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.04 | 52 Week High | $19.62 | |||
| Open | $2.04 | 52 Week Low | $7.65 | |||
| Day High | $2.06 | P/E | N/A | |||
| Day Low | $1.99 | EPS | $-0.22 | |||
| Volume | 7,458,744 | |||||
